Pharmacology, Toxicology and Pharmaceutical Science
microRNA
100%
microRNA 200b
81%
Epidermolysis Bullosa Dystrophica
81%
Squamous Cell Carcinoma
81%
Psoriasis
81%
Ischemic Cardiomyopathy
81%
Heart Infarction
81%
Diacerein
81%
Protein P53
40%
Infarction
40%
Small Interfering RNA
27%
Neoplasm
24%
Cytokine
18%
Dermatitis
18%
Heart Muscle Ischemia
13%
Heart Ventricle Remodeling
13%
Congestive Heart Failure
13%
Rat Model
13%
Biological Marker
13%
Antiapoptotic
13%
Enzyme-Linked Immunosorbent Assay
13%
Splenomegaly
9%
Inflammation
9%
Antiinflammatory Agent
9%
C57BL 6 Mouse
9%
Neovascularization (Pathology)
9%
Imiquimod-Induced Psoriasis
9%
Side Effect
9%
Skin Carcinoma
6%
RNA Directed DNA Polymerase
6%
Metastasis
6%
Survival Time
6%
Western Blot
6%
Disease Course
6%
Flow Cytometry
6%
Immunology and Microbiology
Revertant
81%
Epithelial Mesenchymal Transition
81%
Squamous Cell
81%
Antisense
81%
Exon
40%
Squamous Cell Carcinoma Cell
32%
Squamous Cell Carcinoma Cell Line
32%
Intron
27%
Clinical Decision Making
16%
Survival Time
16%
Genetic Transfection
16%
Angiogenesis
16%
Quantitative Reverse Transcription Polymerase Chain Reaction
16%
Immunofluorescence
16%
Western Blot
16%
Keratinocyte
16%
Basement Membrane
13%
Droplet Digital Polymerase Chain Reaction
13%
Fibril
13%
Dermis
13%
Reverse Transcription Polymerase Chain Reaction
13%
Medicine and Dentistry
Drug Repositioning
81%
Transcriptome
81%
Epidermolysis Bullosa Dystrophica
54%
Squamous Cell Carcinoma
54%
Neoplasm
54%
Skin Carcinoma
27%
Organ Transplantation
27%
Selumetinib
27%
Transplantation
27%
Specific Tumor
27%
Immunosuppressive Treatment
27%
Neck
27%
In Silico
27%
Western Blotting
6%
Biopsy Technique
6%
